Koyfin Home > Directory > Health Care > Akebia Therapeutics > Cash and Short-Term Investments

Akebia Therapeutics Cash and Short-Term Investments Chart (AKBA)

Akebia Therapeutics annual/quarterly Cash and Short-Term Investments from 2012 to 2020.
  • Akebia Therapeutics Cash and Short-Term Investments for the quarter ending June 06, 2020 was $295m a 50.70% increase of 150m year over year
  • Akebia Therapeutics Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $295m a 50.70% increase of 150m year over year
  • Akebia Therapeutics Annual Cash and Short-Term Investments for 2019 was $148m a -117.77% decrease of -174m from 2018
  • Akebia Therapeutics Annual Cash and Short-Term Investments for 2018 was $322m a 1.20% increase of 4m from 2017
  • Akebia Therapeutics Annual Cash and Short-Term Investments for 2017 was $318m a 18.08% increase of 57m from 2016
Other Balance Sheet Metrics:
  • Akebia Therapeutics Total Assets for the quarter ending December 12, 2018 was $997m a 55.57% increase of 554m year over year
  • Akebia Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $95m a 0.76% increase of 1m year over year
  • Akebia Therapeutics Total Equity for the quarter ending December 12, 2018 was $143m a -38.27% decrease of -55m year over year
View Chart On Koyfin

Quarterly AKBA Cash and Short-Term Investments Data

06/2020$295m
03/2020$115m
12/2019$148m
09/2019$146m
06/2019$137m
03/2019$168m
12/2018$322m
09/2018$390m
06/2018$402m
03/2018$393m

Annual AKBA Cash and Short-Term Investments Data

2019$148m
2018$322m
2017$318m
2016$260m
2015$138m
2014$109m
2013$33m
2012$2m
2011$6m